Collplant Biotechnologies Achieves Milestone Regarding Clinical Phase Dermal Filler Product, According To Its Agreement With Abbvie For The Development Of A Regenerative Dermal And Soft Tissue Filler Product, Triggering A Milestone Payment Of $10M
Benzinga Newsdesk - Jun 26, 2023, 7:03AM